Shawn D. Roman's most recent trade in Apyx Medical Corp was a trade of 12,000 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Jan. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apyx Medical Corp | Shawn D. Roman | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.80 per share. | 27 Jan 2026 | 12,000 | 12,000 (0%) | 0% | 1.8 | 21,600 | Common Stock |
| Apyx Medical Corp | Shawn D. Roman | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2026 | 12,000 | 0 | - | - | Stock option (right to buy) | |
| Apyx Medical Corp | Shawn D. Roman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 100,000 | 100,000 | - | - | Stock Option (Option to Buy) |